| # | Drug | Count |
|---|---|---|
| 0 | BREXPIPRAZOLE | 3 |
| 1 | MONTELUKAST SODIUM | 3 |
| 2 | RISPERIDONE | 3 |
| 3 | ARIPIPRAZOLE LAUROXIL | 2 |
| 4 | GUANFACINE | 2 |
| 5 | LAMOTRIGINE | 2 |
| 6 | METHYLPHENIDATE HYDROCHLORIDE | 2 |
| 7 | MONTELUKAST | 2 |
| 8 | ACETAMINOPHEN | 1 |
| 9 | ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | 1 | 0.0005 |
| 1 | ARIPIPRAZOLE LAUROXIL | 2 | 0.0004 |
| 2 | IODIUM,BADIAGA,FUCUS VESICULOSUS,CALCAREAARSENICUM IODATUM, THYROIDINUM,CARBONICA,PULSATILLA,BARYTA CARBONICA, | 1 | 0.0004 |
| 3 | DEXTROMETHORPHAN HYDROBROMIDE, BUPROPION HYDROCHLORIDE | 1 | 0.0003 |
| 4 | GUANFACINE | 2 | 0.0002 |
| 5 | BREXPIPRAZOLE | 3 | 0.0002 |
| 6 | CLONIDINE HYDROCHLORIDE | 1 | 0.0002 |
| 7 | AGALSIDASE BETA | 1 | 0.0001 |
| 8 | GLECAPREVIR AND PIBRENTASVIR | 1 | 0.0001 |
| 9 | FELODIPINE | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] | 1 | 0.0001 |
| 1 | Hepatitis C Virus NS3/4A Protease Inhibitor [EPC] | 1 | 0.0001 |
| 2 | Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC] | 1 | 0.0000 |
| 3 | B Lymphocyte Stimulator-specific Inhibitor [EPC] | 1 | 0.0000 |
| 4 | Sympathomimetic-like Agent [EPC] | 1 | 0.0000 |
| 5 | Hepatitis C Virus NS5A Inhibitor [EPC] | 1 | 0.0000 |
| 6 | Mood Stabilizer [EPC] | 3 | 0.0000 |
| 7 | Anti-epileptic Agent [EPC] | 3 | 0.0000 |
| 8 | Atypical Antipsychotic [EPC] | 6 | 0.0000 |
| 9 | Purine Antimetabolite [EPC] | 1 | 0.0000 |